Global and United States Obesity Management Market Size, Status and Forecast 2021-2027

Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed world. Geriatric people are far more prone to conceal sarcopenia i.e. a noticeable rise in body fat with simultaneous loss of muscle mass and functional capability.
North America is forecast to account for more than 1/3 revenue share of the global obesity management market by 2017 and it should gain a substantial 224 BPS by the year 2025.

Market Analysis and Insights: Global Obesity Management Market
The global Obesity Management market size is projected to reach US$ 7694.8 million by 2027, from US$ 5535.3 million in 2020, at a CAGR of 4.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Obesity Management market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Obesity Management market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Obesity Management market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Obesity Management market.

Global Obesity Management Scope and Market Size
Obesity Management market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Obesity Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug
Surgery

Segment by Application
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Retail Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
GlaxoSmithKline
Orexigen Therapeutics
Arena Pharmaceuticals
VIVUS
Novo Nordisk